# A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative Colitis

> **NCT07747467** · PHASE1 · NOT_YET_RECRUITING · sponsor: **GlaxoSmithKline** · enrollment: 16 (estimated)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **BIOLOGICAL:** Aletekitug (GSK1070806)

## Key facts

- **NCT ID:** NCT07747467
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-10
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-12-04
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07747467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07747467, "A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative Colitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07747467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*